Document is current
Any future updates will be listed below
-
Authors
Mulia, Grace E.
Galindo, Viviana
Chen, Ying-Cheng
Salameh, Janelle W.
Figueiredo, Marxa L. https://orcid.org/0000-0002-8134-0749
-
Funding
Funding for this research was provided by:
National Institutes of Health (UL1TR002529)
- License Information
-
More Information
Article History
Received: 14 March 2025
Accepted: 28 August 2025
First Online: 29 September 2025
Declarations
:
: The animal study was approved by the Purdue Animal Care and Use Committee (PACUC) (Approval number: 1508001279, Title: Experimental therapies for musculoskeletal tissues in the context of tumor, inflammation, and infection; Date: 09/16/2024) and adhered to local legislation and institutional requirements. For human cells: A549 cells were from ATCC, with confirmed initial ethical approval and informed consent from donors; BEAS-2B were from ATCC, with confirmed initial ethical approval and informed consent from donors; hASC cells were purchased from Obatala Sciences, with confirmed initial ethical approval and informed consent from donors.
: Not applicable.
: The authors declare that they have no competing interests.
